EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deciphering the Molecular Complexity of Hepatocellular Carcinoma: Unveiling Novel Biomarkers and Therapeutic Targets Through Advanced Bioinformatics Analysis

Ata Moghimi, Nasrin Bani Hosseinian, Mahdi Mahdipour, Ehsan Ahmadpour, Alberto Miranda-Bedate, Saeid Ghorbian iD

Cancer Reports · 2024

DOI: 10.1002/cnr2.2152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2024. Verfasst von Ata Moghimi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Computational Biology, Biomarkers, Tumor. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) represents a primary liver tumor characterized by a bleak prognosis and elevated mortality rates, yet its precise molecular mechanisms have not been fully elucidated. This study uses advanced bioinformatics techniques to discern differentially expressed genes (DEGs) implicated in the pathogenesis of HCC. The primary objective is to discover novel biomarkers and potential therapeutic targets that can contribute to the advancement of HCC research.

Methods

The bioinformatics analysis in this study primarily utilized the Gene Expression Omnibus (GEO) database as data source. Initially, the Transcriptome analysis console (TAC) screened for DEGs. Subsequently, we constructed a protein–protein interaction (PPI) network of the proteins associated to the identified DEGs with the STRING database. We obtained our hub genes using Cytoscape and confirmed the results through the GEPIA database. Furthermore, we assessed the prognostic significance of the identified hub genes using the GEPIA database. To explore the regulatory interactions, a miRNA‐gene interaction network was also constructed, incorporating information from the miRDB database. For predicting the impact of gene overexpression on drug effects, we utilized CANCER DP.

Results

A comprehensive analysis of HCC gene expression profiles revealed a total of 4716 DEGs, consisting of 2430 upregulated genes and 2313 downregulated genes in HCC sample compared to healthy control group. These DEGs exhibited significant enrichment in key pathways such as the PI3K‐Akt signaling pathway, nuclear receptors meta‐pathway, and various metabolism‐related pathways. Further exploration of the PPI network unveiled the P53 signaling pathway and pyrimidine metabolism as the most prominent pathways. We identified 10 hub genes ( ASPM , RRM2 , CCNB1 , KIF14 , MKI67 , SHCBP1 , CENPF , ANLN , HMMR , and EZH2 ) that exhibited significant upregulation in HCC samples compared to healthy control group. Survival analysis indicated that elevated expression levels of these genes were strongly associated with changes in overall survival in HCC patients. Lastly, we identified specific miRNAs that were found to influence the expression of these genes, providing valuable insights into potential regulatory mechanisms underlying HCC progression.

Conclusion

The findings of this study have successfully identified pivotal genes and pathways implicated in the pathogenesis of HCC. These novel discoveries have the potential to significantly enhance our understanding of HCC at the molecular level, opening new ways for the development of targeted therapies and improved prognosis evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsComputational BiologyBiomarkers, TumorProtein Interaction MapsGene Expression Regulation, NeoplasticGene Expression ProfilingGene Regulatory NetworksHumansPrognosisMicroRNAsTranscriptomeDatabases, GeneticSignal Transduction

Stichwörter der Autor:innen

bioinformaticshepatocellular carcinomahub genesmiRNAs

Substanzen

Biomarkers, TumorMicroRNAs

Autor:innen und Institutionen

  • Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Applied Cell Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Data Science, EURETOS, Utrecht, The Netherlands.
  • Department of Molecular Genetics, Ahar Branch, Islamic Azad University, Ahar, Iran.

ORCID-Profile: Saeid Ghorbian

Zitieren

APA

Moghimi, A., Bani Hosseinian, N., Mahdipour, M., Ahmadpour, E., Miranda-Bedate, A., & Ghorbian, S. (2024). Deciphering the Molecular Complexity of Hepatocellular Carcinoma: Unveiling Novel Biomarkers and Therapeutic Targets Through Advanced Bioinformatics Analysis. Cancer Reports. https://doi.org/10.1002/cnr2.2152

Vancouver

Moghimi A, Bani Hosseinian N, Mahdipour M, Ahmadpour E, Miranda-Bedate A, Ghorbian S. Deciphering the Molecular Complexity of Hepatocellular Carcinoma: Unveiling Novel Biomarkers and Therapeutic Targets Through Advanced Bioinformatics Analysis. Cancer Reports. 2024. doi:10.1002/cnr2.2152

BibTeX
@article{Moghimi2024,
  author = {Moghimi, Ata and Bani Hosseinian, Nasrin and Mahdipour, Mahdi and Ahmadpour, Ehsan and Miranda-Bedate, Alberto and Ghorbian, Saeid},
  title = {Deciphering the Molecular Complexity of Hepatocellular Carcinoma: Unveiling Novel Biomarkers and Therapeutic Targets Through Advanced Bioinformatics Analysis},
  journal = {Cancer Reports},
  year = {2024},
  doi = {10.1002/cnr2.2152}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche